This is a preview of subscription content, log in via an institution to check access.
Reference
Christian S, et al. A single institution comparison of mitoxantrone, etoposide and cytarabine (MEC) vs high-dose cytarabine and mitoxantrone (ARA-C couplets) for treatment of patients with relapsed or refractory acute myeloid leukemia. Blood 130 (Suppl. 1): Dec 2017 [abstract] - USA
Rights and permissions
About this article
Cite this article
Cytarabine/mitoxantrone. Reactions Weekly 1695, 131 (2018). https://doi.org/10.1007/s40278-018-43958-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-43958-x